SCHEMBL1847415

SCHEMBL1847415

O=C(O)Nc1cccc(C(F)(F)F)c1F

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 4/20 0.58
CA12 O43570 1/20 0.56
CA1 P00915 1/20 0.56
CA2 P00918 1/20 0.56
CA9 Q16790 1/20 0.56
TAS2R14 Q9NYV8 2/20 0.49
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
POLB P06746 2/20 0.47
KDM4E B2RXH2 1/20 0.47
GAA P10253 1/20 0.46
RIPK1 Q13546 1/20 0.45
KAT6A Q92794 1/20 0.44
PTGS2 P35354 1/20 0.44
FABP4 P15090 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
ALDH1A1 P00352 1/20 0.43
TSHR P16473 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2755849 0.86 CA12 (0.57) EPHX2CA12CA1CA2CA9
SCHEMBL30499689 0.86 CA12 (0.57) EPHX2CA12CA1CA2CA9
SCHEMBL20560615 0.86 EPHX2 (0.56) EPHX2CA12CA1CA2CA9
SCHEMBL12144664 0.86 EPHX2 (0.57) EPHX2CA12CA1CA2CA9
SCHEMBL1008398 0.85 POLB (0.63) MEN1KMT2APOLBKDM4EGAA
SCHEMBL11067319 0.84 TAS2R14 (0.63) EPHX2TAS2R14MEN1KMT2APOLB
SCHEMBL5917671 0.82 GPR35 (0.49) EPHX2TAS2R14MEN1KMT2APOLB
SCHEMBL12780371 0.82 EPHX2 (0.58) EPHX2CA12CA1CA2CA9
SCHEMBL881580 0.82 CA12 (0.53) EPHX2CA12CA1CA2CA9
SCHEMBL4003395 0.82 EPHX2 (0.56) EPHX2CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2324029-A2 HETEROCYCLIC INHIBITORS OF HISTAMINE RECEPTORS FOR THE TREATMENT OF DISEASE Kalypsys, Inc. (US) 2011-05-25 EP disclosed
WO-2010030785-A2 HETEROCYCLIC INHIBITORS OF HISTAMINE RECEPTORS FOR THE TREATMENT OF DISEASE KALYPSYS INC. (US) 2010-03-18 WO disclosed